Literature DB >> 32339496

Discoidin Domain Receptor 1 (DDR1) Is Necessary for Tissue Homeostasis in Pancreatic Injury and Pathogenesis of Pancreatic Ductal Adenocarcinoma.

Jeanine M Ruggeri1, Janusz Franco-Barraza2, Anjum Sohail3, Yaqing Zhang4, Daniel Long5, Marina Pasca di Magliano4, Edna Cukierman2, Rafael Fridman6, Howard C Crawford7.   

Abstract

Pancreatic ductal adenocarcinoma (PDA) and chronic pancreatitis are characterized by a dense collagen-rich desmoplastic reaction. Discoidin domain receptor 1 (DDR1) is a receptor tyrosine kinase activated by collagens that can regulate cell proliferation, migration, adhesion, and remodeling of the extracellular matrix. To address the role of DDR1 in PDA, Ddr1-null (Ddr-/-) mice were crossed with the KrasG12D/+; Trp53R172H/+; Ptf1aCre/+ (KPC) model of metastatic PDA. Ddr1-/-; KPC mice progress to differentiated PDA but resist progression to poorly differentiated cancer compared with KPC control mice. Strikingly, severe pancreatic atrophy accompanied tumor progression in Ddr1-/-; KPC mice. To further explore the effects of Ddr1 ablation, Ddr1-/- mice were crossed with the KrasG12D/+; Ptf1aCre/+ neoplasia model and subjected to cerulein-induced experimental pancreatitis. Similar to KPC mice, tissue atrophy was a hallmark of both neoplasia and pancreatitis models in the absence of Ddr1. Compared with controls, Ddr1-/- models had increased acinar cell dropout and reduced proliferation with no difference in apoptotic cell death between control and Ddr1-/- animals. In most models, organ atrophy was accompanied by increased fibrillar collagen deposition, suggesting a compensatory response in the absence of this collagen receptor. Overall, these data suggest that DDR1 regulates tissue homeostasis in the neoplastic and injured pancreas.
Copyright © 2020 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32339496      PMCID: PMC7416078          DOI: 10.1016/j.ajpath.2020.03.020

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  42 in total

Review 1.  Molecular subtypes of pancreatic cancer.

Authors:  Eric A Collisson; Peter Bailey; David K Chang; Andrew V Biankin
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-04       Impact factor: 46.802

2.  Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma.

Authors:  Andrew D Rhim; Paul E Oberstein; Dafydd H Thomas; Emily T Mirek; Carmine F Palermo; Stephen A Sastra; Erin N Dekleva; Tyler Saunders; Claudia P Becerra; Ian W Tattersall; C Benedikt Westphalen; Jan Kitajewski; Maite G Fernandez-Barrena; Martin E Fernandez-Zapico; Christine Iacobuzio-Donahue; Kenneth P Olive; Ben Z Stanger
Journal:  Cancer Cell       Date:  2014-05-22       Impact factor: 31.743

3.  Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma.

Authors:  Paolo P Provenzano; Carlos Cuevas; Amy E Chang; Vikas K Goel; Daniel D Von Hoff; Sunil R Hingorani
Journal:  Cancer Cell       Date:  2012-03-20       Impact factor: 31.743

4.  Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma.

Authors:  Chiara Ambrogio; Gonzalo Gómez-López; Mattia Falcone; August Vidal; Ernest Nadal; Nicola Crosetto; Rafael B Blasco; Pablo J Fernández-Marcos; Montserrat Sánchez-Céspedes; Xiaomei Ren; Zhen Wang; Ke Ding; Manuel Hidalgo; Manuel Serrano; Alberto Villanueva; David Santamaría; Mariano Barbacid
Journal:  Nat Med       Date:  2016-02-08       Impact factor: 53.440

Review 5.  Tumor cross-talk networks promote growth and support immune evasion in pancreatic cancer.

Authors:  Christopher J Halbrook; Marina Pasca di Magliano; Costas A Lyssiotis
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-03-15       Impact factor: 4.052

6.  The activated stroma index is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma.

Authors:  Mert Erkan; Christoph W Michalski; Simon Rieder; Carolin Reiser-Erkan; Ivane Abiatari; Armin Kolb; Nathalia A Giese; Irene Esposito; Helmut Friess; Jörg Kleeff
Journal:  Clin Gastroenterol Hepatol       Date:  2008-07-17       Impact factor: 11.382

7.  Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: analysis of histopathology and outcome.

Authors:  Aaron R Sasson; R Wesley Wetherington; John P Hoffman; Eric A Ross; Harry Cooper; Neal J Meropol; Gary Freedman; James F Pingpank; Burton L Eisenberg
Journal:  Int J Gastrointest Cancer       Date:  2003

8.  Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer.

Authors:  Kenneth P Olive; Michael A Jacobetz; Christian J Davidson; Aarthi Gopinathan; Dominick McIntyre; Davina Honess; Basetti Madhu; Mae A Goldgraben; Meredith E Caldwell; David Allard; Kristopher K Frese; Gina Denicola; Christine Feig; Chelsea Combs; Stephen P Winter; Heather Ireland-Zecchini; Stefanie Reichelt; William J Howat; Alex Chang; Mousumi Dhara; Lifu Wang; Felix Rückert; Robert Grützmann; Christian Pilarsky; Kamel Izeradjene; Sunil R Hingorani; Pearl Huang; Susan E Davies; William Plunkett; Merrill Egorin; Ralph H Hruban; Nigel Whitebread; Karen McGovern; Julian Adams; Christine Iacobuzio-Donahue; John Griffiths; David A Tuveson
Journal:  Science       Date:  2009-05-21       Impact factor: 47.728

9.  Mitogen-activated Protein Kinase Kinase Activity Maintains Acinar-to-Ductal Metaplasia and Is Required for Organ Regeneration in Pancreatitis.

Authors:  Christopher J Halbrook; Hui-Ju Wen; Jeanine M Ruggeri; Kenneth K Takeuchi; Yaqing Zhang; Marina Pasca di Magliano; Howard C Crawford
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2017-01

10.  Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy.

Authors:  Hong Jiang; Samarth Hegde; Brett L Knolhoff; Yu Zhu; John M Herndon; Melissa A Meyer; Timothy M Nywening; William G Hawkins; Irina M Shapiro; David T Weaver; Jonathan A Pachter; Andrea Wang-Gillam; David G DeNardo
Journal:  Nat Med       Date:  2016-07-04       Impact factor: 53.440

View more
  8 in total

1.  Beyond Stiffness: Collagen Signaling in Pancreatic Cancer and Pancreas Regeneration.

Authors:  Huocong Huang; Rolf A Brekken
Journal:  Am J Pathol       Date:  2020-05-22       Impact factor: 4.307

2.  Ras-mutant cancers are sensitive to small molecule inhibition of V-type ATPases in mice.

Authors:  Bhairavi Tolani; Anna Celli; Yanmin Yao; Yong Zi Tan; Richard Fetter; Christina R Liem; Adam J de Smith; Thamiya Vasanthakumar; Paola Bisignano; Adam D Cotton; Ian B Seiple; John L Rubinstein; Marco Jost; Jonathan S Weissman
Journal:  Nat Biotechnol       Date:  2022-07-25       Impact factor: 68.164

3.  Identification of Synergistic Drug Combinations to Target KRAS-Driven Chemoradioresistant Cancers Utilizing Tumoroid Models of Colorectal Adenocarcinoma and Recurrent Glioblastoma.

Authors:  Kshama Gupta; Jeremy C Jones; Virginea De Araujo Farias; Yuri Mackeyev; Pankaj K Singh; Alfredo Quiñones-Hinojosa; Sunil Krishnan
Journal:  Front Oncol       Date:  2022-05-18       Impact factor: 5.738

4.  Palladin isoforms 3 and 4 regulate cancer-associated fibroblast pro-tumor functions in pancreatic ductal adenocarcinoma.

Authors:  J I Alexander; D B Vendramini-Costa; R Francescone; T Luong; J Franco-Barraza; N Shah; J C Gardiner; E Nicolas; K S Raghavan; E Cukierman
Journal:  Sci Rep       Date:  2021-02-15       Impact factor: 4.379

5.  Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanoma.

Authors:  Claudia Capparelli; Timothy J Purwin; McKenna Glasheen; Signe Caksa; Manoela Tiago; Nicole Wilski; Danielle Pomante; Sheera Rosenbaum; Mai Q Nguyen; Weijia Cai; Janusz Franco-Barraza; Richard Zheng; Gaurav Kumar; Inna Chervoneva; Ayako Shimada; Vito W Rebecca; Adam E Snook; Kim Hookim; Xiaowei Xu; Edna Cukierman; Meenhard Herlyn; Andrew E Aplin
Journal:  Nat Commun       Date:  2022-03-16       Impact factor: 17.694

Review 6.  New functions of DDR1 collagen receptor in tumor dormancy, immune exclusion and therapeutic resistance.

Authors:  Audrey Sirvent; Kevin Espie; Evangelia Papadopoulou; Dana Naim; Serge Roche
Journal:  Front Oncol       Date:  2022-07-22       Impact factor: 5.738

7.  Inhibition of discoidin domain receptors by imatinib prevented pancreatic fibrosis demonstrated in experimental chronic pancreatitis model.

Authors:  Sapana Bansod; Mohd Aslam Saifi; Chandraiah Godugu
Journal:  Sci Rep       Date:  2021-06-18       Impact factor: 4.379

8.  DDR1-induced neutrophil extracellular traps drive pancreatic cancer metastasis.

Authors:  Jenying Deng; Yaan Kang; Chien-Chia Cheng; Xinqun Li; Bingbing Dai; Matthew H Katz; Taoyan Men; Michael P Kim; Eugene A Koay; Huocong Huang; Rolf A Brekken; Jason B Fleming
Journal:  JCI Insight       Date:  2021-09-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.